Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia

被引：0
|
作者：
Paul Bird
Geoffrey Littlejohn
Belinda Butcher
Tegan Smith
Candida da Fonseca Pereira
David Witcombe
Hedley Griffiths
机构：
[1] OPAL Rheumatology Ltd,
[2] University of New South Wales,undefined
[3] Monash University,undefined
[4] WriteSource Medical Pty Ltd,undefined
[5] Pfizer Australia,undefined
[6] Barwon Rheumatology Service,undefined
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Medication persistence; Real-world; Rheumatoid arthritis; Targeted synthetic disease-modifying antirheumatic drug; TNF-inhibitors; Tofacitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2545 / 2551
页数：6
相关论文
共 50 条
  • [1] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    Pereira, Candida da Fonseca
    Witcombe, David
    Griffiths, Hedley
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2545 - 2551
  • [2] Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
    Littlejohn, Geoffrey
    Leadbetter, Joanna
    Butcher, Belinda E.
    Feletar, Marie
    O'Sullivan, Catherine
    Smith, Tegan
    Witcombe, David
    Ng, Ho Yin
    Youssef, Peter
    [J]. CLINICAL RHEUMATOLOGY, 2024, 43 (05) : 1579 - 1589
  • [3] Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
    Geoffrey Littlejohn
    Joanna Leadbetter
    Belinda E. Butcher
    Marie Feletar
    Catherine O’Sullivan
    Tegan Smith
    David Witcombe
    Ho Yin Ng
    Peter Youssef
    [J]. Clinical Rheumatology, 2024, 43 : 1579 - 1589
  • [4] Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    O'Sullivan, Catherine
    Witcombe, David
    Griffiths, Hedley
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (01) : 53 - 62
  • [5] Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia
    Paul Bird
    Geoffrey Littlejohn
    Belinda Butcher
    Tegan Smith
    Catherine O’Sullivan
    David Witcombe
    Hedley Griffiths
    [J]. Clinical Rheumatology, 2022, 41 : 53 - 62
  • [6] Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
    Bertoldi, Ilaria
    Caporali, Roberto
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2021, 13 : 221 - 237
  • [7] Evaluation of Effectiveness and Usage Patterns of Tofacitinib in Treatment of Rheumatoid Arthritis in Australia: An Analysis from the OPAL-QUMI Real World Dataset
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    Pereira, Candida da Fonseca
    Witcombe, David
    Griffiths, Hedley
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] EVALUATION OF EFFECTIVENESS AND USAGE PATTERNS OF TOFACITINIB IN TREATMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL-QUMI REAL WORLD DATASET
    Bird, Paul
    Littlejohn, Geoff
    Butcher, Belinda
    Smith, Tegan
    Pereira, Candida Da Fonseca
    Witcombe, David
    Griffiths, Hedley
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 740 - 741
  • [9] REAL-WORLD EVALUATION OF TREATMENT PATTERNS AND PERSISTENCE OF TOFACITINIB IN TREATMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS OF THE OPAL DATASET.
    Littlejohn, G.
    Leadbetter, J.
    Butcher, B.
    Feletar, M.
    Osullivan, C.
    Smith, T.
    Witcombe, D.
    Yin, H.
    Youssef, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 820 - 820
  • [10] Real-world experience with tofacitinib for the treatment of rheumatoid arthritis
    Caporali, Roberto
    Zavaglia, Daniela
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 485 - 495
12345